optos plc (OPOSF:OTC US)
Peter J. Fellner Ph.D.
Non-Executive Chairman, Chairman of Nomination Committee, Member of Audit Committee and Member of Remuneration Committee, Optos plc
|Age||Total Calculated Compensation||This person is connected to 81 board members in 9 different organizations across 14 different industries.|
See Board Relationships
Dr. Peter J. Fellner, Ph.D., served as the Chief Executive Officer of Celltech Group PLC from 1990 to 2003. Dr. Fellner joined Celltech from Roche UK, where he served as the Chief Executive from 1986 to 1990. He served as Director of Research at Searle UK Research Laboratories. He has been Non Executive Chairman of Ablynx NV since November 12, 2013. He has been the Non-Executive Chairman at Optos PLC since January 1, 2010. He has been the Chairman of Consort Medical ...
Queensferry HousePhone: 44 13 8384 3300
Dunfermline, Fife KY11 8GR
Fax: 44 1383 843 337
Board Members Memberships*
Vice Chairman and Member of Governance & Nominating Committee
Non Executive Director and Chairman of Remuneration Committee
Chairman and Chairman of Nomination Committee
Non Executive Director, Chairman of Nominations Committee and Member of Remuneration Committee
Non-Executive Chairman and Chairman of Nominations & Corporate Governance Committee
Non-Executive Chairman, Chairman of Nomination Committee, Member of Audit Committee and Member of Remuneration Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Clive A. Meanwell M.D., Ph.D.||Chairman and Chief Executive Officer|
The Medicines Company
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Jean-Christophe Tellier||Chief Executive Officer and Executive Director|
|--||Compensation as of Fiscal Year 2014.|